🇺🇸 FDA
Patent

US 12270050

Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and using

granted A61KA61K40/11A61K40/31

Quick answer

US patent 12270050 (Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and using) held by Regents of the University of Minnesota expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K40/11, A61K40/31, A61K40/4211